Literature DB >> 29753796

The Neuroendocrinology of the Microbiota-Gut-Brain Axis: A Behavioural Perspective.

Sofia Cussotto1, Kiran V Sandhu2, Timothy G Dinan3, John F Cryan4.   

Abstract

The human gut harbours trillions of symbiotic bacteria that play a key role in programming different aspects of host physiology in health and disease. These intestinal microbes are also key components of the gut-brain axis, the bidirectional communication pathway between the gut and the central nervous system (CNS). In addition, the CNS is closely interconnected with the endocrine system to regulate many physiological processes. An expanding body of evidence is supporting the notion that gut microbiota modifications and/or manipulations may also play a crucial role in the manifestation of specific behavioural responses regulated by neuroendocrine pathways. In this review, we will focus on how the intestinal microorganisms interact with elements of the host neuroendocrine system to modify behaviours relevant to stress, eating behaviour, sexual behaviour, social behaviour, cognition and addiction.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Addiction; Corticosterone; Eating behaviour; HPA axis; Hormones; Learning; Neuroendocrine system; Sexual behaviour; Social behaviour; Stress

Mesh:

Year:  2018        PMID: 29753796     DOI: 10.1016/j.yfrne.2018.04.002

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  65 in total

Review 1.  Inflammation in Mental Disorders: Is the Microbiota the Missing Link?

Authors:  Sophie Ouabbou; Ying He; Keith Butler; Ming Tsuang
Journal:  Neurosci Bull       Date:  2020-06-27       Impact factor: 5.203

Review 2.  Mood-related central and peripheral clocks.

Authors:  Kyle D Ketchesin; Darius Becker-Krail; Colleen A McClung
Journal:  Eur J Neurosci       Date:  2018-11-29       Impact factor: 3.386

3.  Maternal and Breast Milk Influences on the Infant Gut Microbiome, Enteric Health and Growth Outcomes of Rhesus Monkeys.

Authors:  Danielle Nicole Rendina; Gabriele R Lubach; Gregory J Phillips; Mark Lyte; Christopher L Coe
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-09       Impact factor: 2.839

Review 4.  A biological framework for emotional dysregulation in alcohol misuse: from gut to brain.

Authors:  Carina Carbia; Séverine Lannoy; Pierre Maurage; Eduardo López-Caneda; Kenneth J O'Riordan; Timothy G Dinan; John F Cryan
Journal:  Mol Psychiatry       Date:  2020-12-07       Impact factor: 15.992

Review 5.  Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience.

Authors:  M C Flux; Christopher A Lowry
Journal:  Neurobiol Dis       Date:  2019-08-24       Impact factor: 5.996

Review 6.  Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System.

Authors:  Richa Jalodia; Yaa Fosuah Abu; Mark Ryan Oppenheimer; Bridget Herlihy; Jingjing Meng; Irina Chupikova; Junyi Tao; Nillu Ghosh; Rajib Kumar Dutta; Udhghatri Kolli; Yan Yan; Eridania Valdes; Madhulika Sharma; Umakant Sharma; Shamsudheen Moidunny; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2022-01-07       Impact factor: 4.147

7.  Potential Role of Epigenetics and Redox Signaling in the Gut-Brain Communication and the Case of Autism Spectrum Disorder.

Authors:  Ceymi Doenyas
Journal:  Cell Mol Neurobiol       Date:  2021-11-13       Impact factor: 5.046

8.  Supplementation of Lactobacillus early in life alters attention bias to threat in piglets.

Authors:  Else Verbeek; Johan Dicksved; Linda Keeling
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

Review 9.  The role of the gut microbiome in opioid use.

Authors:  Michelle Ren; Shahrdad Lotfipour
Journal:  Behav Pharmacol       Date:  2020-04       Impact factor: 2.293

10.  Alterations of gut microbiota composition in post-finasteride patients: a pilot study.

Authors:  F Borgo; A D Macandog; S Diviccaro; E Falvo; S Giatti; G Cavaletti; R C Melcangi
Journal:  J Endocrinol Invest       Date:  2020-09-19       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.